Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 6-MTH group results

Nov 10 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2020        Sep 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             17.39               16.45            40.80    
                 (+5.7 pct)          (-5.3 pct)       (+18.0 pct) 
  Operating          3.74                3.04             8.00    
                 (+23.1 pct)         (+15.7 pct)      (+27.5 pct) 
  Recurring          3.82                2.96             8.10    
                 (+29.0 pct)         (+10.9 pct)      (+27.6 pct) 
  Net                2.27                2.08             5.00    
                 (+9.6 pct)          (+20.6 pct)      (+30.9 pct) 
  EPS             18.89 yen           17.23 yen        41.52 yen  
  Ann Div                             8.00 yen         9.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             8.00 yen         9.00 yen   
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news